Overview

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
Phase 1 2-part study to evaluate the effect of food on pharmacokinetics of pelabresib (CPI-0610) and the effect of pelabresib on QTc in patients with advanced malignancies
Phase:
Phase 1
Details
Lead Sponsor:
Constellation Pharmaceuticals